Neurosense Therapeutics Ltd (NRSN) — Free Cash Flow Generation Index
Latest as of June 2023:
1.00x
Neurosense Therapeutics Ltd (NRSN) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of $1.78K represents 1% of operating cash flow ($1.78K). See NRSN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$1.78K
USD
Operating Cash Flow
$1.78K
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Neurosense Therapeutics Ltd (None–None)
Year-by-year Free Cash Flow Generation Index for Neurosense Therapeutics Ltd. For the full company profile including market capitalisation, see Neurosense Therapeutics Ltd (NRSN) total market value.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).